Update From ESC24: New Data on Non-Statin Lipid Lowering Therapies and Reduced CV Risk

Venous Thromboembolism - Risk Assessment

A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center

A Scientific and Practical Guide to the Administration and Monitoring of FcRn Blockers for Generalized Myasthenia Gravis in the Infusion Center

Best Practices for Implementing Dual Endothelin Angiotensin Receptor Antagonist Therapeutics in Patients with IgAN

Optimal Contemporary Management of Hypertrophic Cardiomyopathy: The Importance of Early Diagnosis and Targeted Therapy